To investigate whether garlic extract modulates invasive capability of HER2+ breast tumor cells, both cell lines were treated with LYO for 72 h and subjected to real-time analysis with xCELLigence RTCA technology. The gene discussed is ERBB2; the disease is breast neoplasm.